The Latest Cardiac and Vascular News
SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that the company’s Common Stock has been listed on the NASDAQ Global Market. Ontrak shares will continue to trade under the ticker “OTRK.” Mr. Terren Peizer, the Company’s […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of positive new Phase 1/2 clinical data on two RNAi-based cardiometabolic candidates, ARO-APOC3 targeting apolipoprotein C-III (APOC3) being developed as a treatment for patients with hypertriglyceridemia, and ARO-ANG3 targeting angiopoietin like protein 3 (ANGPTL3) being developed as a treatment […]
HELP Study results, evaluating levosimendan in patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF), will be presented during a Late-Breaking Clinical Trial session during the HFSA Annual Scientific Meeting MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing […]
Medical device and analytics veteran brings 15 years of senior leadership experience and a proven track record of value creation SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company, today announced the appointment of Michael Thompson as President, effective September 8, 2020. Thompson will assume day to day operational responsibility […]
Press release Horsham, UK 01 September 2020 Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly- differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including […]
Philips introduces Affiniti CVx and Release 7.0 of EPIQ CVx with breakthrough interventional and productivity features to support cardiology departments managing everyday challenges Philips debuts impactful solutions in cardiology at ESC 2020 (Aug 29 – Sept 1) Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health […]
Topline data expected first quarter 2021 BEDMINSTER, N.J., Aug. 27, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has completed enrollment in the ENHANCE-IT Study (Pharmacodynamic Effects of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids to ENHANCE Efficacy in Adults with Hypertriglyceridemia), a […]
NILEMDO® (bempedoic acid) is a new, first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering treatment that significantly reduces LDL-C on top of statins and other lipid-lowering therapies1 Bempedoic acid acts on the well-known cholesterol synthesis pathway, upstream of the statin target in the liver1 Due to its unique mechanism of action, bempedoic […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Intact Vascular, Inc., a U.S.-based developer of medical devices for minimally-invasive peripheral vascular procedures. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform […]
by Tori Leets | Aug 25, 2020 | Ken Dropiewski, Placement Announcement McDermott + Bull has successfully placed Scott VanderMeer as the Vice President of Sales at Clarius Mobile Health. As a member of Clarius’s senior leadership team, Scott will play a vital role in achieving commercial success through revenue and market share objectives, positioning the […]
